Abstract:Objective To evaluate the feasibility of transarterial prostate embolization for reducing the volume and its technical safety in hormone-induced dogs prostate hyperplasia.Methods Prostate hyperplasia was induced on 12 adult male dogs by administering testosterone propionate for 12 weeks.Then,the dogs were randomly assigned to transarterial prostatic embolization group (n =6) and control group (n =6).Twelve weeks after initiating the hormone treatment,6 animals in transarterial prostatic embolization group underwent prostatic arterial embolization with Embospheres 100-300 μm in diameter.Based on MRI,the volume of prostate was measured for both groups on the three time points:before injection of hormone (BI),before the procedure of prostatic arterial embolization (BP) and 12 weeks after the procedure of prostatic arterial embolization (AP).Finally,the prostates and surrounding tissues were harvested for histopathology study.A statistical software package (SPSS version 19.0) was used for analysis.Measurement data were expressed as x-± s.Samples paired t test was used to compare the prostatic volume between BP and AP.The t test was applied in the intergroup comparison.P ＜ 0.05 was considered to indicate a statistically significant difference.Results The successful rate of BPH model establishment and superselective catheterization were 100％.No serious procedure-related complication was observed.After 12 weeks of hormone administration,the mean volume of prostate was 19.5 ± 2.5 mm3 in embolization group and 19.2 ±3.8 mm3 in control group before prostatic arterial embolization,without statistical difference(t =0.14,P ＞0.05).At 12 weeks after prostatic arterial embolization,the mean volume of prostate was 6.1 ± 1.4 mm3 in embolization group and 17.8 ± 3.5 mm3 in control group with significant statistical difference (t =-7.6,P ＜ 0.05).Compared with pretreatment measurement,the mean volume of prostate decreased by 68.7％ at 12 weeks after prostatic arterial embolization with significant statistical difference (t =10.7,P ＜ 0.05).But there was no statistical difference between the two time points in control group with a 7.3％ mean decrease (t =1.4,P ＞0.05).Histopathology study revealed that embosphere particles had occluded partial arterioles of the prostate in the embolization group of dogs.Near the occluded arterioles,normal gland structure disappeared; while residual gland tissue appeared to be atrophied.In embolization group,there was no gross or microscopic change in the surrounding tissues including bladder,deferent duct and rectum.Extensive prostate glandular hyperplasia was observed in control group.Conclusions Transcatheter arterial embolization is feasible for reducing prostate volume without serious complication in hormone-induced prostate hyperplasia dogs and worthy of further investigation.

Mechanism of the experimental animal study on composite balloon transurethral balloon dilatation of prostate treatment of benign prostatic hyperplasia

The value of transurethral cylindrical dilatation of the prostate in the treatment of patients with benign prostatic hyperplasia

High-pressure Balloon Dilation for Male Anterior Urethral Stricture: Single-Center Experience

The Effect of Transurethral Resection of the Prostate on Erectile Function

High-risk benign prostatic hyperplasia patients treated with transurethral resection of prostate

[Transurethral columnar balloon dilation of the prostate for benign prostatic hyperplasia]

[Effect of Electrovaporization on the Prostate and Its Surrounding Tissues].

Efficacy and Safety of Transurethral Columnar Balloon Dilation of the Prostate for the Treatment of Benign Prostatic Hyperplasia: A Multicenter Trial

One-year Effect of Ultrasound Guided Transurethral Balloon Dilation of Prostate for the Treatment of Benign Prostatic Hyperplasia

[Transurethral resection of the prostate versus transurethral columnar balloon dilatation of the prostate in the treatment of benign prostatic hyperplasia]

Transarterial Prostatic Embolization: Initial Experience in Hormone-Induced Benign Prostatic Hyperplasia in Dogs

A multicenter retrospective study of transurethral prostate split for benign prostate hyperplasia

Prostatic elasticity: a new non-invasive parameter to assess bladder outlet obstruction caused by benign prostatic hyperplasia (a canine experiment).

Evaluation of the Effects of Temporary Covered Nitinol Stent Placement in the Prostatic Urethra: Short-Term Study in the Canine Model

Laparoscopic Simple Prostatectomy with Prostatic Urethra Preservation for Benign Prostatic Hyperplasia

Comparison of two different methods of establishment of canine urethroplasty model: an experimental trial

Efficacy of Transurethral Resection of the Microscope over the Same Period of Benign Prostatic Hyperplasia and Bladder Stones

Experience in Diagnosis and Treatment for Small-Size Benign Prostatic Hyperplasia

Transurethral domestic 1470 nm laser vaporization for the treatment of <30 g small-volume benign prostatic hyperplasia

Transurethral bipolar plasmakinetic prostatectomy for benign prostatic hyperplasia in high-risk and senior patients in China: a systematic review and meta-analysis

The effect of bladder function on the efficacy of transurethral prostatectomy in patients with benign prostatic hyperplasia: a retrospective, single-center study